ALT001 is named as a drug or biological intervention in 3 clinical trials in our China trial register, 3 of which are recruiting. Lead sponsors include yilong Wang (2) and Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1). Registered phases: Phase EARLY_PHASE1 and Not applicable. Conditions studied include Multiple System Atrophy; Multiple System Atrophy - Cerebellar Subtype (MSA-C); Osteoarthritis.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07476352 | Expansion Study of ALT001 in Patients With Multiple System Atrophy (ClinicalTrials.gov ↗) Multiple System Atrophy |
Phase EARLY_PHASE1 | Recruiting |
| NCT07514923 | The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type (ClinicalTrials.gov ↗) Multiple System Atrophy - Cerebellar Subtype (MSA-C) |
Phase EARLY_PHASE1 | Recruiting |
| NCT07404891 | Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis (ClinicalTrials.gov ↗) Osteoarthritis |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Multiple System Atrophy | 1 |
| Multiple System Atrophy - Cerebellar Subtype (MSA-C) | 1 |
| Osteoarthritis | 1 |
| Lead sponsor | Trials |
|---|---|
| yilong Wang | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| Register | ALT001 trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how ALT001 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists ALT001 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.